These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 11831889
21. A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements. De Luca S, Ragone R, Bracco C, Digilio G, Aloj L, Tesauro D, Saviano M, Pedone C, Morelli G. Chembiochem; 2003 Nov 07; 4(11):1176-87. PubMed ID: 14613109 [Abstract] [Full Text] [Related]
23. CCK-A- and CCK-B-like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis). Oliver AS, Vigna SR. Gen Comp Endocrinol; 1997 Jan 07; 105(1):91-101. PubMed ID: 9000471 [Abstract] [Full Text] [Related]
25. Folded conformations of antigenic peptides from riboflavin carrier protein in aqueous hexafluoroacetone. Bhattacharjya S, Awasthi SK, Adiga PR, Balaram P. Protein Sci; 1998 Jan 07; 7(1):123-31. PubMed ID: 9514267 [Abstract] [Full Text] [Related]
26. Conformational stability of a thrombin-binding peptide derived from the hirudin C-terminus. Ni F, Ripoll DR, Purisima EO. Biochemistry; 1992 Mar 10; 31(9):2545-54. PubMed ID: 1547237 [Abstract] [Full Text] [Related]
27. Molecular modelling of CCK-A receptors. Van Der Bent A, Ijzerman AP, Soudijn W. Drug Des Discov; 1994 Nov 10; 12(2):129-48. PubMed ID: 9116168 [Abstract] [Full Text] [Related]
30. Receptor fragment approach to the binding between CCK8 peptide and cholecystokinin receptors: a fluorescence study on type B receptor fragment CCK(B)-R (352-379). De Luca S, Sanseverino M, Zocchi I, Pedone C, Morelli G, Ragone R. Biopolymers; 2005 Mar 10; 77(4):205-11. PubMed ID: 15666329 [Abstract] [Full Text] [Related]
31. Synthetic interface peptides as inactivators of multimeric enzymes: inhibitory and conformational properties of three fragments from Lactobacillus casei thymidylate synthase. Prasanna V, Bhattacharjya S, Balaram P. Biochemistry; 1998 May 12; 37(19):6883-93. PubMed ID: 9578575 [Abstract] [Full Text] [Related]
33. Metal ion binding affinities of gastrin and CCK in membrane mimetic environments. Lutz J, Weyher E, Moroder L. J Pept Sci; 1995 May 12; 1(6):360-70. PubMed ID: 9223015 [Abstract] [Full Text] [Related]
35. Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function. Harikumar KG, Dong M, Cheng Z, Pinon DI, Lybrand TP, Miller LJ. Biochemistry; 2006 Dec 12; 45(49):14706-16. PubMed ID: 17144663 [Abstract] [Full Text] [Related]
36. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer. Harikumar KG, Pinon DI, Wessels WS, Dawson ES, Lybrand TP, Prendergast FG, Miller LJ. Mol Pharmacol; 2004 Jan 12; 65(1):28-35. PubMed ID: 14722234 [Abstract] [Full Text] [Related]
37. Conformationally readdressed CCK-B/delta-opioid peptide ligands. Nikiforovich GV, Kolodziej SA, Nock B, Bernad N, Martinez J, Marshall GR. Biopolymers; 1995 Oct 12; 36(4):439-52. PubMed ID: 7578939 [Abstract] [Full Text] [Related]
39. Conformation of N-terminal HIV-1 Tat (fragment 1-9) peptide by NMR and MD simulations. Kanyalkar M, Srivastava S, Coutinho E. J Pept Sci; 2001 Nov 12; 7(11):579-87. PubMed ID: 11763362 [Abstract] [Full Text] [Related]
40. On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system. Pincus MR, Carty RP, Chen J, Lubowsky J, Avitable M, Shah D, Scheraga HA, Murphy RB. Proc Natl Acad Sci U S A; 1987 Jul 12; 84(14):4821-5. PubMed ID: 3037525 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]